Assessment of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy in Specialist Hospital, Jalingo, North-Eastern Nigeria.
| dc.contributor.author | Giwa A., Sabum C., Giwa H. B., Jamiu M.O | |
| dc.date.accessioned | 2023-05-17T09:38:43Z | |
| dc.date.available | 2023-05-17T09:38:43Z | |
| dc.date.issued | 2021-09 | |
| dc.description.abstract | Background: This study aimed to assess Health-Related Quality of Life (HRQoL) in cancer patients receiving chemotherapy in Specialist Hospital, Jalingo, North-Eastern Nigeria, in 2015. Methods: A cross-sectional study was conducted on 218 cancer patients selected by systematic random sampling method. The study data were collected using a modified European Organization for Research and Treatment of Cancer QoL Questionnaire (EORTC QLQ-C30 v. 3). Results: Out of the 218 participants, 42(18.8%) had between 1 to 4 chemotherapy cycles, while 86(39.4%) had 5 to 8 cycles and the remaining 91(41.7%) had 9 to 12 chemotherapy cycles. There was a significant relationship between HRQoL and the number of chemotherapy cycles received. Conclusion: Encouraging cancer patients to complete a chemotherapy course plays an essential role in the treatment outcome and the HRQoL in cancer patients undergoing chemotherapy. | en_US |
| dc.identifier.citation | Giwa A., Sabum C., Giwa H. B., Jamiu M.O. (2021). Assessment of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy in Specialist Hospital, Jalingo, North-Eastern Nigeria. Journal of Pharmacoeconomics and Pharmaceutical Management, 7 (3); 100-112. | en_US |
| dc.identifier.issn | 2383-4498 | |
| dc.identifier.uri | https://uilspace.unilorin.edu.ng/handle/20.500.12484/10300 | |
| dc.publisher | Tehran University of Medical Sciences | en_US |
| dc.subject | Anticancer, Quality of life, Cycles of chemotherapy, Nigeria | en_US |
| dc.title | Assessment of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy in Specialist Hospital, Jalingo, North-Eastern Nigeria. | en_US |